M
MedZERO
Mobile lending platform dedicated to serving the healthcare industry
About MedZERO
MedZERO is a healthcare-focused fintech company that provides an employer-sponsored financial wellness platform. The company's main service is offering employees on-demand, interest-free, and fee-free funds to cover their out-of-pocket medical expenses. This allows employees to pay for their healthcare costs over time, making medical treatments more affordable and accessible.
The platform is designed to help both employees and employers manage healthcare costs effectively. For employees, it provides a straightforward way to finance medical bills without incurring debt. For employers, it serves as a valuable employee benefit that can improve financial wellness and retention.
MedZERO operates on a B2B2C model, partnering with employers to offer its services to their workforce. The company's revenue is generated through its partnerships with employers, who sponsor the platform for their employees. The company is based in Portland, Oregon, and was founded in 2017.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Portland, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
True Ventures
Village Global
LG Nova
Series A5 investors entered at this stage
Grand Ventures
Capital Eleven
Riverwalk Capital Partners
Elevate Capital
Jumpstart Nova
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedZERO on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedZERO on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.